chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Myalgia, Pyrexia, Sluggishness
Clinical narrative: no appetite; no energy; in bed for 3 days; sluggish; fever; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), ASTHENIA (no energy), VACCINATION COMPLICATION (in bed for 3 days), SLUGGISHNESS (sluggish) and PYREXIA (fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (no energy), VACCINATION COMPLICATION (in bed for 3 days), SLUGGISHNESS (sluggish), PYREXIA (fever) and MYALGIA (sore arm). At the time of the report, DECREASED APPETITE (no appetite), ASTHENIA (no energy), VACCINATION COMPLICATION (in bed for 3 days), SLUGGISHNESS (sluggish), PYREXIA (fever) and MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment provided by the reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: no appetite; no energy; in bed for 3 days; sluggish; fever; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), ASTHENIA (no energy), VACCINATION COMPLICATION (in bed for 3 days), SLUGGISHNESS (sluggish) and PYREXIA (fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (no energy), VACCINATION COMPLICATION (in bed for 3 days), SLUGGISHNESS (sluggish), PYREXIA (fever) and MYALGIA (sore arm). At the time of the report, DECREASED APPETITE (no appetite), ASTHENIA (no energy), VACCINATION COMPLICATION (in bed for 3 days), SLUGGISHNESS (sluggish), PYREXIA (fever) and MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (swelling of feet) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced peripheral swelling (swelling of feet). At the time of the report, peripheral swelling (swelling of feet) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache, Myalgia, Nausea, Neck pain
Clinical narrative: stomach pain; neck pain; Does the medication give you pain under your armpit for your neck all the way down to your fingertips/my fingertips under my armpits by my boob; Head pain/headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain), NECK PAIN (neck pain), MYALGIA (Does the medication give you pain under your armpit for your neck all the way down to your fingertips/my fingertips under my armpits by my boob), HEADACHE (Head pain/headache) and NAUSEA (nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), NECK PAIN (neck pain), MYALGIA (Does the medication give you pain under your armpit for your neck all the way down to your fingertips/my fingertips under my armpits by my boob), HEADACHE (Head pain/headache) and NAUSEA (nausea). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain), NECK PAIN (neck pain), MYALGIA (Does the medication give you pain under your armpit for your neck all the way down to your fingertips/my fingertips under my armpits by my boob), HEADACHE (Head pain/headache) and NAUSEA (nausea) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       No concomitant medications reported.  No treatment information was provided.   This case was linked to MOD-2021-265761 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Follow-up received included: updated action taken, added events and updated narrative
Sex: U
Vaccine: COVID19
Symptoms: Ocular hyperaemia
Clinical narrative: A blood clot behind left eye; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (A blood clot behind left eye) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OCULAR HYPERAEMIA (A blood clot behind left eye). At the time of the report, OCULAR HYPERAEMIA (A blood clot behind left eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.  No treatment medication was provided.  The patient received first shot in February.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: curious side effects; This spontaneous case was reported by a consumer and describes the occurrence of vaccination complication in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (curious side effects). At the time of the report, VACCINATION COMPLICATION (curious side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Myalgia, Rash, Swelling face
Clinical narrative: swelling in the lower part of his eyes; rash on his whole body; face swollen, red and hard; face swollen, red and hard; pain in the arm and a little body ache; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face swollen, red and hard), ERYTHEMA (face swollen, red and hard), EYE SWELLING (swelling in the lower part of his eyes), RASH (rash on his whole body) and MYALGIA (pain in the arm and a little body ache) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Cardiac disorder.    On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, the patient experienced MYALGIA (pain in the arm and a little body ache). On 26-Jun-2021, the patient experienced SWELLING FACE (face swollen, red and hard), ERYTHEMA (face swollen, red and hard) and RASH (rash on his whole body). On an unknown date, the patient experienced EYE SWELLING (swelling in the lower part of his eyes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 26-Jun-2021, MYALGIA (pain in the arm and a little body ache) had resolved. At the time of the report, SWELLING FACE (face swollen, red and hard), ERYTHEMA (face swollen, red and hard), EYE SWELLING (swelling in the lower part of his eyes) and RASH (rash on his whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included high blood pressure medication, for cardiac problem.  Treatment information included steroid pills.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination related malaise; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination related malaise) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 15-Feb-2021.   In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination related malaise). At the time of the report, VACCINATION COMPLICATION (Vaccination related malaise) had not resolved.            The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) was Not Applicable. No concomitant medications were reported. No treatment details were reported.   This case was linked to MOD-2021-239052 (Patient Link).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding
Clinical narrative: Non stop periods/DUB DUB DUB kind of  non stop drip./Non severe periods; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Non stop periods/DUB DUB DUB kind of  non stop drip./Non severe periods) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 042B21A) for COVID-19 vaccination.     Concurrent medical conditions included Behcet's syndrome. Concomitant products included AZATHIOPRINE SODIUM (IMURAN [AZATHIOPRINE SODIUM]) and COLCHICINE for Behcet's syndrome.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (Non stop periods/DUB DUB DUB kind of  non stop drip./Non severe periods). At the time of the report, HEAVY MENSTRUAL BLEEDING (Non stop periods/DUB DUB DUB kind of  non stop drip./Non severe periods) outcome was unknown.            No treatment medication details was reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 21-Jun-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Pain
Clinical narrative: I miserable; hurt all over/Pain won't subside; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (I miserable) and PAIN (hurt all over/Pain won't subside) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (I miserable) and PAIN (hurt all over/Pain won't subside). At the time of the report, FEELING ABNORMAL (I miserable) and PAIN (hurt all over/Pain won't subside) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jun-2021, Body temperature: 102-103 (High) Fever is between 102 and 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported by the reporter Treatment drugs were not reported by the reporter
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Illness
Clinical narrative: Very ill right now; Have turned red; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very ill right now) and ERYTHEMA (Have turned red ) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very ill right now) and ERYTHEMA (Have turned red ). At the time of the report, ILLNESS (Very ill right now) and ERYTHEMA (Have turned red ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No concomitant medication were reported. No treatment information was reported
Sex: U
Vaccine: COVID19
Symptoms: Aphasia, Gait disturbance, Pain in extremity
Clinical narrative: I Can't talk/without a voice; pain in both legs; hard to walk; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Jun-2021 and was forwarded to Moderna on 28-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of APHASIA (I Can't talk/without a voice), PAIN IN EXTREMITY (pain in both legs) and GAIT DISTURBANCE (hard to walk) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced APHASIA (I Can't talk/without a voice), PAIN IN EXTREMITY (pain in both legs) and GAIT DISTURBANCE (hard to walk). At the time of the report, APHASIA (I Can't talk/without a voice), PAIN IN EXTREMITY (pain in both legs) and GAIT DISTURBANCE (hard to walk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea a side affect from vaccine shot the second time; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea a side affect from vaccine shot the second time) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea a side affect from vaccine shot the second time). At the time of the report, DIARRHOEA (diarrhea a side affect from vaccine shot the second time) outcome was unknown.            No concomitant medication information as provided.  No treatment information was provided.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Faeces soft, Pain in extremity, Rhinorrhoea
Clinical narrative: Diarrhea; Soft stool; Runny nose; Sore arm; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIARRHOEA (Diarrhea), FAECES SOFT (Soft stool), RHINORRHOEA (Runny nose) and PAIN IN EXTREMITY (Sore arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN, APIXABAN (ELIQUIS), FUROSEMIDE, HYDRALAZINE and METOPROLOL for an unknown indication.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), FAECES SOFT (Soft stool), RHINORRHOEA (Runny nose) and PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), FAECES SOFT (Soft stool) and RHINORRHOEA (Runny nose) had not resolved and PAIN IN EXTREMITY (Sore arm) outcome was unknown.            Concomitant products also included an unspecified thyroid medication.  The reporter stated the patient received the first dose of Moderna COVID-19 Vaccine in the beginning of Feb-2021, and the second dose was administered in the beginning of Mar-2021.
Sex: U
Vaccine: COVID19
Symptoms: Musculoskeletal pain
Clinical narrative: some pain in between my shoulder blades for two days / YES; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL PAIN (some pain in between my shoulder blades for two days / YES) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL PAIN (some pain in between my shoulder blades for two days / YES). At the time of the report, MUSCULOSKELETAL PAIN (some pain in between my shoulder blades for two days / YES) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Spinal pain
Clinical narrative: leg pain; spine pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (leg pain) and SPINAL PAIN (spine pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (leg pain) and SPINAL PAIN (spine pain). At the time of the report, PAIN IN EXTREMITY (leg pain) and SPINAL PAIN (spine pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache/really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache/really bad headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Medical history was not provided. .     On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2021, the patient experienced HEADACHE (Headache/really bad headache). At the time of the report, HEADACHE (Headache/really bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-up received on 28-Jun-2021 Email ID was added.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Drug hypersensitivity, Rash, Skin reaction
Clinical narrative: becoming allergic to Tylenol and ibuprofen & Sensitive to food that contained salicylate; any new supplement or drug she tries he has a reaction dermatologically; arms burn like sunburn; rash under the skin; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (becoming allergic to Tylenol and ibuprofen & Sensitive to food that contained salicylate), SKIN REACTION (any new supplement or drug she tries he has a reaction dermatologically), BURNING SENSATION (arms burn like sunburn) and RASH (rash under the skin) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (becoming allergic to Tylenol and ibuprofen & Sensitive to food that contained salicylate), SKIN REACTION (any new supplement or drug she tries he has a reaction dermatologically), BURNING SENSATION (arms burn like sunburn) and RASH (rash under the skin). At the time of the report, HYPERSENSITIVITY (becoming allergic to Tylenol and ibuprofen & Sensitive to food that contained salicylate), SKIN REACTION (any new supplement or drug she tries he has a reaction dermatologically), BURNING SENSATION (arms burn like sunburn) and RASH (rash under the skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-239128 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Faeces soft, Rhinorrhoea
Clinical narrative: Soft stool; Diarrhea; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of FAECES SOFT (Soft stool), DIARRHOEA (Diarrhea) and RHINORRHOEA (Runny nose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy (Has allergies once a year with seasonal change).   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FAECES SOFT (Soft stool), DIARRHOEA (Diarrhea) and RHINORRHOEA (Runny nose). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form. At the time of the report, FAECES SOFT (Soft stool), DIARRHOEA (Diarrhea) and RHINORRHOEA (Runny nose) had resolved.            No concomitant medication were reported. Patient recently had and abdominal ultrasound to see what could be causing the gastro-intestinal issues and waiting for results. Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-239104 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Outcome of the events updated. Lab test results awaiting. On 26-Jul-2021: Follow up Contains No new information.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Glycosylated haemoglobin, Hyperhidrosis, Illness
Clinical narrative: side effect after being vaccinated; Sleep all day; NAUSEA; got sick; sweating profusely; Hot; Tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect after being vaccinated ), HYPERHIDROSIS (sweating profusely), FEELING HOT (hot), SOMNOLENCE (Sleep all day) and ILLNESS (got sick) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018BZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN LISPRO (HUMALOG), INSULIN GLARGINE (LANTUS) and METFORMIN for Diabetes, ATORVASTATIN, OMEPRAZOLE and VITAMIN D3 for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced HYPERHIDROSIS (sweating profusely), FEELING HOT (hot) and FATIGUE (Tired). On 30-Mar-2021, the patient experienced ILLNESS (got sick). On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect after being vaccinated ), SOMNOLENCE (Sleep all day) and NAUSEA (NAUSEA). On 01-Mar-2021, HYPERHIDROSIS (sweating profusely), FEELING HOT (hot) and FATIGUE (Tired) outcome was unknown. On 30-Mar-2021, ILLNESS (got sick) outcome was unknown. At the time of the report, VACCINATION COMPLICATION (side effect after being vaccinated ), SOMNOLENCE (Sleep all day) and NAUSEA (NAUSEA) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Glycosylated haemoglobin: increased to 8.5% from being in the 7's (Inconclusive) increased to 8.5% from being in the 7's.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant follow up :- additional information( adverse events, suspect drug details, concomitant medications) added On 28-Jun-2021: Non-significant follow up appended
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Somnolence, Vaccination complication
Clinical narrative: side effect after being vaccinated; Sleep all day; NAUSEA; got sick; sweating profusely; Hot; Tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect after being vaccinated ), HYPERHIDROSIS (sweating profusely), FEELING HOT (hot), SOMNOLENCE (Sleep all day) and ILLNESS (got sick) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018BZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN LISPRO (HUMALOG), INSULIN GLARGINE (LANTUS) and METFORMIN for Diabetes, ATORVASTATIN, OMEPRAZOLE and VITAMIN D3 for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced HYPERHIDROSIS (sweating profusely), FEELING HOT (hot) and FATIGUE (Tired). On 30-Mar-2021, the patient experienced ILLNESS (got sick). On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect after being vaccinated ), SOMNOLENCE (Sleep all day) and NAUSEA (NAUSEA). On 01-Mar-2021, HYPERHIDROSIS (sweating profusely), FEELING HOT (hot) and FATIGUE (Tired) outcome was unknown. On 30-Mar-2021, ILLNESS (got sick) outcome was unknown. At the time of the report, VACCINATION COMPLICATION (side effect after being vaccinated ), SOMNOLENCE (Sleep all day) and NAUSEA (NAUSEA) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Glycosylated haemoglobin: increased to 8.5% from being in the 7's (Inconclusive) increased to 8.5% from being in the 7's.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant follow up :- additional information( adverse events, suspect drug details, concomitant medications) added On 28-Jun-2021: Non-significant follow up appended
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD, Thyroid disorder, Psychosis, Barrett's esophagus and Depression. Concomitant products included SUCRALFATE and PANTOPRAZOLE for Barrett's esophagus, IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (COMBIVENT) for COPD, TRAZODONE for Depression, DULOXETINE for Psychosis, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, CLONAZEPAM (KLONOPIN) and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant treatment included nebulizer for COPD. Treatment information was not provided.   This case was linked to MOD-2021-239105 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, X-ray
Clinical narrative: Difficulty breathing, winded, cant catch her breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing, winded, cant catch her breath) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing, winded, cant catch her breath). The patient was treated with PREDNISONE for Adverse event, at a dose of UNK dosage form. At the time of the report, DYSPNOEA (Difficulty breathing, winded, cant catch her breath) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported Treatment medication includes: Inhaler   This case was linked to MOD-2021-239133 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: very achy right leg just below hip on right side of leg; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (very achy right leg just below hip on right side of leg) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.    On 26-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jun-2021, the patient experienced PAIN IN EXTREMITY (very achy right leg just below hip on right side of leg). At the time of the report, PAIN IN EXTREMITY (very achy right leg just below hip on right side of leg) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No relevant concomitant medications were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Skin lesion
Clinical narrative: skin lesions; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (skin lesions) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN LESION (skin lesions). At the time of the report, SKIN LESION (skin lesions) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Myalgia, Paraesthesia
Clinical narrative: Numbness fingers; Tingling sensation; Soreness of the arm after both doses; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness fingers), PARAESTHESIA (Tingling sensation) and MYALGIA (Soreness of the arm after both doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness fingers), PARAESTHESIA (Tingling sensation) and MYALGIA (Soreness of the arm after both doses). The patient was treated with VITAMIN B12 NOS for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (Numbness fingers) and PARAESTHESIA (Tingling sensation) had not resolved and MYALGIA (Soreness of the arm after both doses) outcome was unknown.            Concomitant product use was not provided.   Other treatment information included application of ice the area.   This case was linked to MOD-2021-239025, MOD-2021-239025 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Head discomfort
Clinical narrative: head pressure; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (head pressure) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (head pressure). At the time of the report, HEAD DISCOMFORT (head pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy (Patient has allergies once a year with seasonal change.).    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   This case was linked to MOD-2021-239096 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up included no new information
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mobility decreased, Myalgia
Clinical narrative: m in bed for the whole day; severe body aches all over; headaches; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (m in bed for the whole day), MYALGIA (severe body aches all over) and HEADACHE (headaches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (COMBIVENT), DULOXETINE HYDROCHLORIDE (DULOXETINE [DULOXETINE HYDROCHLORIDE]), LEVOTHYROXINE SODIUM (SYNTHROID), SUCRALFATE, PANTOPRAZOLE, CLONAZEPAM, TRAZODONE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (m in bed for the whole day), MYALGIA (severe body aches all over) and HEADACHE (headaches). At the time of the report, MOBILITY DECREASED (m in bed for the whole day), MYALGIA (severe body aches all over) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment included Neubilizer   This case was linked to MOD-2021-239098 (Patient Link).
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Acne
Clinical narrative: Something that looks like Acne appeared on both sides of their temples; This spontaneous case was reported by a pharmacist and describes the occurrence of ACNE (Something that looks like Acne appeared on both sides of their temples) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ACNE (Something that looks like Acne appeared on both sides of their temples). At the time of the report, ACNE (Something that looks like Acne appeared on both sides of their temples) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Vaccination site pain, Vaccination site reaction
Clinical narrative: soreness of the arm after the vaccine; numbness on two fingers/numb on the arm; Different reactions; Get totally numb on the arm; Radiating tingling sensation going up their arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness of the arm after the vaccine), HYPOAESTHESIA (numbness on two fingers/numb on the arm), VACCINATION SITE REACTION (Different reactions), HYPOAESTHESIA (Get totally numb on the arm) and PARAESTHESIA (Radiating tingling sensation going up their arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness of the arm after the vaccine), HYPOAESTHESIA (numbness on two fingers/numb on the arm), VACCINATION SITE REACTION (Different reactions), HYPOAESTHESIA (Get totally numb on the arm) and PARAESTHESIA (Radiating tingling sensation going up their arm). The patient was treated with VITAMIN B12 NOS for Adverse event, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (soreness of the arm after the vaccine), HYPOAESTHESIA (numbness on two fingers/numb on the arm), VACCINATION SITE REACTION (Different reactions) and PARAESTHESIA (Radiating tingling sensation going up their arm) outcome was unknown and HYPOAESTHESIA (Get totally numb on the arm) had resolved.            No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-Up information received on 28-JUN-2021 doesn't contain any significant information. On 28-Jun-2021: Follow-Up information received on 28-JUN-2021 doesn't contain any significant information.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Vaccination site reaction
Clinical narrative: I did not feel well for 24 hours; Covid-arm; throbbing headache; tiredness; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (I did not feel well for 24 hours), VACCINATION SITE REACTION (Covid-arm), HEADACHE (throbbing headache) and FATIGUE (tiredness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20a and 030m20a) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for High cholesterol, VITAMIN D NOS for Vitamin D decreased.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (I did not feel well for 24 hours), VACCINATION SITE REACTION (Covid-arm), HEADACHE (throbbing headache) and FATIGUE (tiredness). At the time of the report, MALAISE (I did not feel well for 24 hours), VACCINATION SITE REACTION (Covid-arm), HEADACHE (throbbing headache) and FATIGUE (tiredness) outcome was unknown.            Treatment included icepack and antihistamine. EpiPen was ordered in case of emergency.  .Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-018146 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (vomiting). At the time of the report, VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Dose administered after exceeded storage guidelines; Dose administered after exceeded storage guidelines; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Dose administered after exceeded storage guidelines) and EXPIRED PRODUCT ADMINISTERED (Dose administered after exceeded storage guidelines) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2021, the patient experienced PRODUCT STORAGE ERROR (Dose administered after exceeded storage guidelines) and EXPIRED PRODUCT ADMINISTERED (Dose administered after exceeded storage guidelines). At the time of the report, PRODUCT STORAGE ERROR (Dose administered after exceeded storage guidelines) and EXPIRED PRODUCT ADMINISTERED (Dose administered after exceeded storage guidelines) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 8 weeks since first dose; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (8 weeks since first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (8 weeks since first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (8 weeks since first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.